BVS Earnings

Quarterly EPS
$-0.08
Q3 2024
$-0.01
Q4 2024
$-0.04
Q1 2025
$0.11
Q2 2025
$0.05
Q3 2025
$0.22
Q4 2025
$0.05
Q1 2026
$0.49
Q2 2026
Latest Revenue153.2M
Latest Net Income36.2M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.49153.2M36.2M+3.8%+345.5%
Q1 2026$0.05132.1M3.9M+6.6%+225.0%
Q4 2025$0.22157.9M17.3M+2.8%+2,300.0%
Q3 2025$0.05138.7M4.0M-0.2%+162.5%
Q2 2025$0.11147.7M9.3M-2.4%+127.5%
Q1 2025-$0.04123.9M-3322000-4.3%+50.0%
Q4 2024-$0.01153.6M-603000+13.5%+90.0%
Q3 2024-$0.08139.0M-5848000+15.0%+33.3%
Q2 2024-$0.40151.2M-34217000
Q1 2024-$0.08129.5M-6381000
Q4 2023-$0.10135.4M-22593000
Q3 2023-$0.12120.8M-8791000
Bioventus (BVS) — Earnings